Level has designed Openwater, a non-invasive Low-Intensity Focused Ultrasound (LIFU), pioneering the use of infrared and ultrasound to safely treat devastating diseases, showing early success in trials for cancer, mental illness and stroke.
By reducing million-dollar MRI machines to $1,000 portable devices and accelerating FDA-approved novel therapeutic development by 85 per cent, Openwater is making life-saving technology more accessible. Openwater's approach – leveraging software, hardware and AI – enables rapid iteration akin to consumer electronics.
Addressing and treating the world's most devastating diseases is costly and time-intensive. By sharing R&D within the Open Source community, Openwater fosters rapid innovation and collaboration, significantly reducing costs and time to market for new medical devices.
This shift from expensive, inaccessible diagnostic tools to portable, AI-powered solutions will democratise healthcare worldwide, making non-invasive, highly effective treatments the new standard of care.
Openwater is revolutionising healthcare by pioneering the use of infrared and ultrasound to treat the world's most devastating diseases, where, over the past 12 months, Openwater has achieved significant milestones, underscoring the success of our innovative medical technology.
This project has been longlisted in the product design (health, wellbeing and wearables) category of Dezeen Awards 2025.
